Recently, SCLC lacking high expression of ASCL1, NEUROD1, and POU2F3 have been re-categorized on the basis of their inflamed gene signature, including immune checkpoint genes and human leukocyte antigens (HLAs), rather than solely based on the expression of YAP112. This evidence concerns the gene NEUROD1 and small cell lung carcinoma.